Predictive Technology Group Inc (PRED)

[PRED2020]

What happened to the $10 MILLION to $50 million?
Cost of goods sold in the diagnostics and therapeutics segment for the three months ended December 31, 2020 increased to $1.0 million from zero due to the introduction of the Assurance VR COVID-19 RT-PCR viral test during the six months ended December 31, 2020. The profitability of the COVID-19 testing business is sensitive to testing volume, with higher marginal profitability per unit after fixed costs are covered.